Cancer Therapies Access Debate

Full Debate: Read Full Debate

Baroness Wheeler

Main Page: Baroness Wheeler (Labour - Life peer)

Cancer Therapies Access

Baroness Wheeler Excerpts
Monday 6th February 2023

(1 year, 10 months ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate
Lord Evans of Rainow Portrait Lord Evans of Rainow (Con)
- View Speech - Hansard - - - Excerpts

My noble friend raises a very good point. One in two of us will develop cancer in the future, so we need to explore all therapies or vaccines wherever possible.

Baroness Wheeler Portrait Baroness Wheeler (Lab)
- View Speech - Hansard - -

My Lords, Cancer Research UK has shown that the annual rate of cancer diagnosis will increase by one-third over the next two decades, rising to nearly half a million. It takes 15 years to train an oncologist, pathologist or surgeon. In the light of previous questions, will the Minister assure the House that the long-awaited NHS workforce plan, when it is finally published, will address these particular shortages? How will the workforce plan dovetail with the also promised major conditions strategy, which the Government have announced that they are now putting in place of the 10-year cancer strategy, as we previously heard, which itself was long overdue?

Lord Evans of Rainow Portrait Lord Evans of Rainow (Con)
- View Speech - Hansard - - - Excerpts

My Lords, I can assure the noble Baroness that the new major conditions strategy will set out a strong and coherent policy agenda that sets out a shift to integrate whole-person care. Interventions set out in the strategy will aim to alleviate pressure on the health system as well as support the Government’s objective of increasing healthy-life expectancy and reducing ill-health-related labour market inactivity. We will cover the patient pathway from prevention to treatment and set out the standards patients should expect in the short term and over a five-year lifetime. Many stakeholders have already responded to the Government’s call for evidence on cancer.